Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Trop2”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Not applicableUnknownNCT03529604
What this trial is testing

Salivary Ap4A, SCCA, TROP2 in Oral Cancer Patients

Who this might be right for
Oral Cavity Squamous Cell CarcinomaSaliva AlteredPrecancerous Lesions
University of Zagreb 100
Early research (Phase 1)Looking for participantsNCT06066424
What this trial is testing

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

Who this might be right for
Solid Tumors
M.D. Anderson Cancer Center 54
Not applicableStudy completedNCT05708144
What this trial is testing

NIR Fluorescent Molecular Probe for the Identification of Breast Tissue

Who this might be right for
Breast Cancer
Xiang'an Hospital of Xiamen University 26
Early research (Phase 1)Looking for participantsNCT06929663
What this trial is testing

AK146D1 for Injection in the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Akeso 48
Large-scale testing (Phase 3)Active Not RecruitingNCT05687266
What this trial is testing

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

Who this might be right for
NSCLC
AstraZeneca 1,350
Not applicableLooking for participantsNCT07026110
What this trial is testing

Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer

Who this might be right for
Lung CancerLung DiseasesLung Neoplasms+2 more
RenJi Hospital 100
Not applicableEnded earlyNCT06465017
What this trial is testing

ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

Who this might be right for
TumorSolid TumorThyroid Cancer+1 more
The First Affiliated Hospital of Xiamen University 149
Not applicableLooking for participantsNCT06715839
What this trial is testing

Target-specific immunoPET Imaging of Digestive System Carcinoma

Who this might be right for
MalignancyDigestive CancerDigestive System Neoplasm+12 more
RenJi Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT06902389
What this trial is testing

A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Eastern Hepatobiliary Surgery Hospital 30
Not applicableLooking for participantsNCT06203574
What this trial is testing

Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors

Who this might be right for
Positron-Emission TomographyNeoplasms
Huashan Hospital 60
Testing effectiveness (Phase 2)UnknownNCT05928780
What this trial is testing

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 125
Not applicableNot Yet RecruitingNCT07068542
What this trial is testing

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

Who this might be right for
Advanced Thyroid CarcinomaRadioiodine-refractory Differentiated Thyroid Cancer
Zhejiang Provincial People's Hospital 55
Early research (Phase 1)Active Not RecruitingNCT05174637
What this trial is testing

FDA018-ADC in Patients With Advanced Solid Tumors

Who this might be right for
Advanced/ Metastatic Solid Tumors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 78
Testing effectiveness (Phase 2)Ended earlyNCT06865677
What this trial is testing

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Who this might be right for
Recurrent Platinum Resistant Epithelial Ovarian CarcinomaRecurrent Epithelial Endometrial CarcinomaRecurrent Epithelial Cervical Carcinoma
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Looking for participantsNCT06878625
What this trial is testing

A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 138
Not applicableNot Yet RecruitingNCT06934733
What this trial is testing

The Efficacy of Oral Cryotherapy in Preventing TROP2-ADC-Induced Oral Mucositis in Patients With Advanced Breast Cancer

Who this might be right for
Advanced or Metastatic Breast Cancer
Henan Cancer Hospital 124
Large-scale testing (Phase 3)Looking for participantsNCT06074588
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC 556
Large-scale testing (Phase 3)Looking for participantsNCT06841354
What this trial is testing

Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Who this might be right for
Triple Negative Breast Neoplasms
Merck Sharp & Dohme LLC 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05838521
What this trial is testing

Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
Yale University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06464055
What this trial is testing

GQ1010 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd. 260
Load More Results